Acute Myocardial Infarction: Pathophysiology and Treatment
This paper provides a structured overview of acute myocardial infarction (AMI), covering its pathophysiology, aetiology, clinical features, diagnosis, complications, and treatment options. It examines how atherosclerotic plaque rupture triggers thrombus formation and coronary occlusion, leading to irreversible myocardial damage. The paper also applies this knowledge to a patient case study, explaining how uncontrolled risk factors — including hypertension, hyperlipidaemia, and smoking — contribute to AMI onset. Specific clinical manifestations such as chest pain and haemodynamic compromise are explained mechanistically, and the pharmacological rationale for treatments including glyceryl trinitrate, aspirin, and heparin is discussed.
- Overview and Epidemiology: Definition, prevalence, and classification of AMI types
- Pathogenesis and Disease Progression: Endothelial disruption, thrombus formation, and cell death
- Clinical Features, Diagnosis, and Treatment: Symptoms, ECG markers, reperfusion, and prevention
- Case Analysis: Risk Factors and Plaque Rupture: How Mr. White's risk factors led to AMI
- Case Analysis: Clinical Manifestations Explained: Mechanistic explanation of chest pain and low blood pressure
- Case Analysis: Pharmacological Management: Rationale for GTN, aspirin, and heparin use
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper moves logically from foundational pathophysiology to applied clinical reasoning, reinforcing each concept before applying it to the patient case.
- Case-based questions are answered with direct mechanistic explanations that tie back to the disease process described in the template section, demonstrating integrated understanding.
- The pharmacological rationale for each treatment is clearly linked to the underlying pathology, showing why each drug is appropriate rather than simply naming it.
Key academic technique demonstrated
The paper demonstrates mechanistic clinical reasoning — the ability to connect cellular and vascular pathophysiology to observable patient symptoms and therapeutic choices. For example, lactic acid accumulation is cited as the biochemical cause of chest pain, and impaired cardiac contractility is used to explain the paradoxically low blood pressure in a hypertensive patient.
Structure breakdown
The paper is divided into two main parts. The first is a structured pathophysiology template covering disease definition, aetiology, pathogenesis, clinical features, complications, prognosis, diagnosis, treatment, and prevention. The second part responds to three case-based questions about a patient named Mr. White, applying each layer of the template to explain his presentation and management. This format suits health sciences courses that require both theoretical knowledge and clinical application.
Overview and Epidemiology
Acute myocardial infarction is a common disease with very grave consequences in morbidity, mortality, and cost to society (Boersma et al., 2003). It has become the leading cause of death in the developed world. It has been estimated that approximately 450,000 people die from coronary disease per year in the United States.
Myocardial infarction primarily occurs when the blood supply to the heart is compromised. Just like all cells of the body, myocardial cells require a constant supply of blood and oxygen to keep functioning. Ischemia beyond a set threshold level exhausts the cells and causes them to be damaged. The term myocardial infarction should be used when there is evidence of necrosis of the myocardium in a clinical setting.
There are five different types of MI, defined according to the clinical situation. Type 1 is a spontaneous MI associated with a primary coronary event, such as occlusion by a thrombus due to plaque rupture. Type 2 is associated with ischemia resulting from a mismatch between increased demand and reduced supply. Type 3 is an MI linked to sudden cardiac death. Types 4 and 5 are MIs associated with percutaneous coronary intervention and coronary artery bypass surgery, respectively.
Aetiology
Many risk factors have been identified in the development of atherosclerotic changes that lead to MI. The six principal factors are increased cholesterol levels, hypertension, diabetes mellitus, tobacco use, a family history of atherosclerotic disease, and male gender.
Pathogenesis and Disease Progression
Most myocardial infarctions are initiated by a disruption in the vascular endothelium. Ongoing atherosclerotic processes stimulate the formation of an intracoronary thrombus. The thrombus then lodges inside a coronary artery and ultimately causes occlusion of blood flow. If the blockage of the coronary artery persists for more than twenty minutes, irreversible damage to muscle cells occurs and ultimately cell death results (Kumar & Abbas et al., 2005).
Course of Disease
The course of the disease depends on how effectively the offending agent is treated. As noted above, irreversible damage occurs to the heart if ischemia persists for more than twenty minutes. The course therefore varies with the cause of the MI, the area of the heart involved, and the treatment administered to the patient.
Complications
The complications of acute myocardial infarction include ventricular arrhythmias, cardiac rupture (Rosamond et al., 1998), acute mitral insufficiency, heart failure, and mural thrombosis (Keeley et al., 1996).
Prognosis
Improvement in prognosis over the last decade has been driven mainly by early treatment with reperfusion and thrombolytic agents (Hayashi et al., 2005).
Create your account
Always verify citation format against your institution’s current style guide requirements.